건강 지식

Hypertension Guide: How to Measure at Home, What Counts as High, and How Much Lifestyle Alone Can Do

Beyond CKD 11 분 소요

About 1.3 billion adults have hypertension and nearly half don't know it. Based on the 2017 ACC/AHA, 2023 ESH and 2024 ESC guidelines, this guide covers correct home measurement, how the thresholds differ, how many mmHg each lifestyle change is worth, and when to seek care immediately.

목차
  1. Why hypertension is called the "silent killer"
  2. What counts as high? Three guidelines compared
  3. Measuring at home: the "7-2-2 rule"
  4. How much can lifestyle lower it without pills?
  5. Targets: is lower always better?
  6. Special notes for kidney patients and transplant recipients
  7. When to seek care immediately
  8. Questions to ask your doctor
  9. References

Why hypertension is called the "silent killer"

High blood pressure usually causes no symptoms, yet it is the single largest modifiable risk factor for death worldwide. WHO estimates that in 2019 about 1.28 billion adults aged 30–79 had hypertension, 46% were unaware, and only about 21% had it controlled [1]. Over years, raised pressure damages the vessel lining and leads to stroke, heart attack, heart failure, chronic kidney disease and dementia.

For people with kidney disease, hypertension is both a cause and a consequence of CKD: falling kidney function → salt and water retention and renin activation → higher pressure → higher glomerular pressure → faster decline. Breaking that loop is one of the most effective ways to slow CKD [5].

What counts as high? Three guidelines compared

Office BP (mmHg) 2017 ACC/AHA (US) [2] 2023 ESH / 2024 ESC (Europe) [3][4]
<120 / <80 Normal Optimal
120–129 / <80 Elevated Normal
130–139 / 80–89 Stage 1 hypertension High-normal / ESC 2024 "elevated BP"
140–159 / 90–99 Stage 2 Grade 1
≥160 / ≥100 Stage 2 Grade 2–3
≥180 / ≥120 Hypertensive crisis Grade 3 / emergency

The difference lies in the 130–139/80–89 band: the US labels it stage 1 (usually managed with lifestyle first), Europe calls it high-normal. Both agree: ≥140/90 must be treated, and most people should aim for <130/80 if tolerated [2][3][4].

Taiwan's 2022 guideline uses home BP ≥130/80 mmHg as the diagnostic threshold and recommends home measurement as the primary method [6].

Measuring at home: the "7-2-2 rule"

Office readings are inflated by the "white-coat effect"; home readings better reflect true pressure and better predict cardiovascular events [2][3]. Taiwan's guideline summarises this as 7-2-2 [6]:

  • 7 consecutive days
  • 2 sessions a day (within 1 hour of waking; before bed)
  • 2 readings per session, 1 minute apart, averaged

Technique matters as much as the device [2][3]:

  1. No smoking, caffeine or exercise for 30 minutes; empty your bladder first.
  2. Sit quietly for 5 minutes, feet flat, back supported.
  3. Arm resting on a table with the cuff at heart level; don't roll sleeves tightly.
  4. Use an upper-arm automated device (wrist devices are less accurate); the cuff must fit your arm circumference.
  5. Don't talk or use your phone during the reading.
  6. Bring a new device to a clinic visit once to compare against the staff's reading.

Home thresholds are 5 mmHg lower than office: a home average ≥135/85 (ESH) or ≥130/80 (ACC/AHA, Taiwan) corresponds to office hypertension [2][3][6].

How much can lifestyle lower it without pills?

Guidelines give concrete averages (individual responses vary widely) [2][3]:

Intervention Mean systolic reduction Notes
Weight loss ≈ −1 mmHg per kg lost Target BMI 18.5–24.9 (lower cut-offs, <23–24, often used for Asian populations)
DASH diet ≈ −11 mmHg in hypertensives Fruit, vegetables, whole grains, low-fat dairy; less red meat and sweets
Sodium reduction ≈ −5 to −6 mmHg Target <1,500–2,000 mg sodium/day (≈4–5 g salt); DASH-Sodium showed the combination works best [7]
More dietary potassium ≈ −4 to −5 mmHg From fruit and vegetables; ask your doctor first if CKD stage 3+ or on potassium-sparing drugs (see below)
Exercise aerobic −5 to −8; resistance −4 ≥150 min/week moderate aerobic + resistance training 2–3 days/week
Limit alcohol ≈ −4 mmHg ≤2 drinks/day men, ≤1 women; none is best

Combined, many people with stage 1 hypertension can avoid or reduce medication. But if BP is still ≥140/90 after 3–6 months, or starts at ≥160/100, or you already have diabetes, CKD or cardiovascular disease, guidelines recommend starting medication at the same time [2][3].

Targets: is lower always better?

SPRINT (9,361 high-risk adults without diabetes) showed that targeting systolic <120 versus <140 cut major cardiovascular events by 25% and all-cause death by 27%, but with more hypotension, syncope, acute kidney injury and electrolyte disturbances [8]. Note that SPRINT used unattended automated office measurement, which reads 5–10 mmHg lower than routine office BP.

Current consensus [2][3][4][5]:

  • Most adults: <130/80 if tolerated.
  • Over 65: ESH accepts systolic 130–139; lower if fit and tolerated.
  • CKD: KDIGO 2021 suggests systolic <120 (standardised office measurement, if tolerated); evidence is insufficient for dialysis and transplant patients, so individualise [5].
  • Diabetes: <130/80.

"If tolerated" matters: dizziness, blackouts on standing or falls mean the target should be revisited, not endured.

Special notes for kidney patients and transplant recipients

  • Potassium: the DASH diet and "eat more fruit and veg" advice can cause hyperkalaemia if eGFR <45 or you take an ACEi/ARB or MRA (spironolactone, finerenone). Use this site's potassium lookup and talk to a dietitian.
  • ACEi/ARB are first-line in CKD with albuminuria; a creatinine rise of ≤30% after starting is expected and not a reason to stop, but potassium must be monitored [5].
  • Dialysis: pre-, intra- and post-dialysis pressures differ widely; interdialytic home BP matters most, and targets should be set individually with your nephrologist.
  • Transplant: tacrolimus and steroids raise BP; amlodipine is often first choice, but diltiazem/verapamil sharply raise tacrolimus levels — check this site's interaction lookup first.
  • Painkillers: NSAIDs raise BP and blunt antihypertensives; kidney patients should avoid them.

When to seek care immediately

Call emergency services or go to the ED now (hypertensive emergency) [2]:

  • BP ≥180/120 plus any of: severe headache, chest pain, breathlessness, blurred vision, slurred speech or one-sided weakness, confusion, seizure, blood in urine or sudden drop in urine output.

Same or next day:

  • BP ≥180/120 without those symptoms → rest 5 minutes and re-measure; if still high, contact your doctor today.
  • Home average ≥160/100 for a week.
  • New leg swelling or breathlessness when lying flat.

Routine appointment: home average persistently ≥130/80, or erratic readings despite medication.

Questions to ask your doctor

  1. Given my age and kidney function, what is my target?
  2. How does my home log (exportable from this site's BP tool) compare with office readings? Do I need 24-hour monitoring?
  3. Am I taking anything that raises BP (NSAIDs, steroids, decongestants, oral contraceptives)?
  4. Can I eat more fruit and vegetables, or is my potassium a concern?
  5. Should I have a urine albumin test (UACR) and kidney function check?

References

  1. World Health Organization. Global report on hypertension: the race against a silent killer. 2023. https://www.who.int/publications/i/item/9789240081062
  2. Whelton PK, et al. 2017 ACC/AHA Guideline for High Blood Pressure in Adults. Hypertension. 2018;71(6):e13–e115. https://doi.org/10.1161/HYP.0000000000000065
  3. Mancia G, et al. 2023 ESH Guidelines for the management of arterial hypertension. J Hypertens. 2023;41(12):1874–2071. https://doi.org/10.1097/HJH.0000000000003480
  4. McEvoy JW, et al. 2024 ESC Guidelines for elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912–4018. https://doi.org/10.1093/eurheartj/ehae178
  5. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD. Kidney Int. 2021;99(3S):S1–S87. https://doi.org/10.1016/j.kint.2020.11.003
  6. Wang TD, et al. 2022 Taiwan Hypertension Guidelines. Acta Cardiol Sin. 2022;38(3):225–325. https://doi.org/10.6515/ACS.202205_38(3).20220321A
  7. Sacks FM, et al. DASH-Sodium trial. N Engl J Med. 2001;344(1):3–10. https://doi.org/10.1056/NEJM200101043440101
  8. SPRINT Research Group. Intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–2116. https://doi.org/10.1056/NEJMoa1511939

This article compiles publicly available medical information for educational purposes only. It is not medical advice and has not been reviewed by a practising physician. For any health or medication question, consult a qualified professional. For chest pain, sudden breathlessness, one-sided weakness or slurred speech, call your local emergency number or go to the emergency department immediately.

변경 기록

  • 初版:依 2017 ACC/AHA、2023 ESH、2024 ESC 高血壓指引與 SPRINT、DASH-Sodium 試驗整理。
공유:
다른 언어로 읽기:English日本語繁體中文

Where to go next

Related knowledge

Lived experience

독립적으로 운영하며, 건강 정보를 더 쉽게 이해하고 찾을 수 있도록 노력합니다.

BeyondCKD는 신장 건강과 통합 케어를 중심으로 하는 독립 건강 정보 플랫폼입니다. 의학 연구, 진료 지침, 실용적인 자료를 정리하여 흩어진 정보를 이해하기 쉽고 찾기 쉬우며 바로 활용할 수 있는 콘텐츠로 만들어, 다양한 건강 단계에 있는 분들이 더 근거 있는 선택을 하도록 돕습니다.

본 사이트는 의료 관련 업체의 유료 게재를 받지 않으며, 상업적 제휴가 추천 내용을 좌우하지 않습니다. 운영은 명확히 표시된 광고와 제휴 링크로 지원될 수 있으며, 모든 협력은 투명성 원칙에 따라 공개하고 콘텐츠 판단의 근거로 삼지 않습니다. 자세한 내용은제휴 마케팅 공개。

콘텐츠 정리, 자료 유지, 도구 개발, 다국어 업데이트에는 지속적인 시간과 자원이 필요합니다. BeyondCKD가 도움이 되었다면, 이러한 자료가 계속 유지되고 더 많은 사람에게 전해질 수 있도록 후원해 주시면 감사하겠습니다.

후원하기